EUVIMEDEUVIMED entdecken
Crossref

OptoBarrier: An Optogenetic Platform for Modulating Endothelial Barriers In Vitro

Sharon Fleischer iD, Martin Liberman iD, Max Summers, Vanessa Li, Trevor R Nash iD, Gordana Vunjak-Novakovic iD

ACS Biomaterials Science & Engineering · 2025

DOI: 10.1021/acsbiomaterials.5c00708 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Biomaterials Science & Engineering, 2025. Verfasst von Sharon Fleischer und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Columbia University, New York, New York 10032, United States. Hauptthemen laut MEDLINE: Optogenetics, Endothelial Cells, Lab-On-A-Chip Devices. Die Arbeit nennt 48 Literaturangaben. Gefördert von: Directorate for Biological Sciences, National Heart, Lung, and Blood Institute, National Institute of Biomedical Imaging and Bioengineering.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Organ-on-a-chip platforms have emerged as promising human tissue models for drug screening and mechanistic studies, offering alternatives to traditional animal models. Integration of vascular structures into these platforms is pivotal for creating physiologically faithful models of individual organs and studying interorgan crosstalk. However, most vascular structures grown in vitro do not account for organ-specific endothelial permeability or its modulation in response to disease. Here, we present optoBarrier, an optogenetic organ-on-a-chip platform designed to modulate endothelial barrier permeability through light stimulation. By optically activating RhoA signaling in engineered optogenetic endothelial cells, we demonstrate the formation of stress fibers, disruption of vascular endothelial cadherin (VE-cadherin) and increased barrier permeability. We further show that permeability is tunable in a reversible and dose-dependent manner in response to light. We therefore propose that optoBarrier offers a user-defined, controlled and simple method to manipulate endothelial permeability for in vitro studies of human vasculature.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OptogeneticsEndothelial CellsLab-On-A-Chip DevicesHumansHuman Umbilical Vein Endothelial CellsCadherinsrhoA GTP-Binding ProteinAntigens, CDCapillary PermeabilitySignal TransductionCadherin 5

Stichwörter der Autor:innen

engineered vasculaturein vitro modelingoptogeneticsorgan-on-a-chipvascular permeability

Substanzen

CadherinsrhoA GTP-Binding ProteinAntigens, CDCadherin 5

Autor:innen und Institutionen

  • Department of Biomedical Engineering, Columbia University, New York, New York 10032, United States.
  • Department of Medicine, Columbia University, New York, New York 10032, United States.
  • College of Dental Medicine, Columbia University, New York, New York 10032, United States.

ORCID-Profile: Sharon Fleischer, Martin Liberman, Trevor R Nash, Gordana Vunjak-Novakovic

Förderung

  • Directorate for Biological Sciences
  • National Heart, Lung, and Blood Institute
  • National Institute of Biomedical Imaging and Bioengineering

Zitieren

APA

Fleischer, S., Liberman, M., Summers, M., Li, V., Nash, T. R., & Vunjak-Novakovic, G. (2025). OptoBarrier: An Optogenetic Platform for Modulating Endothelial Barriers In Vitro. ACS Biomaterials Science & Engineering. https://doi.org/10.1021/acsbiomaterials.5c00708

Vancouver

Fleischer S, Liberman M, Summers M, Li V, Nash TR, Vunjak-Novakovic G. OptoBarrier: An Optogenetic Platform for Modulating Endothelial Barriers In Vitro. ACS Biomaterials Science & Engineering. 2025. doi:10.1021/acsbiomaterials.5c00708

BibTeX
@article{Fleischer2025,
  author = {Fleischer, Sharon and Liberman, Martin and Summers, Max and Li, Vanessa and Nash, Trevor R and Vunjak-Novakovic, Gordana},
  title = {OptoBarrier: An Optogenetic Platform for Modulating Endothelial Barriers In Vitro},
  journal = {ACS Biomaterials Science & Engineering},
  year = {2025},
  doi = {10.1021/acsbiomaterials.5c00708}
}
Kostenlos starten →